PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Feb-2023 Palleon Pharmaceuticals to Present at the Guggenheim Healthcare Talks Oncology Day Businesswire
07-Feb-2023 Ankyra Therapeutics Announces Collaboration to Evaluate ANK-101 in Early Clinical Trials Focused on Lung Cancer Businesswire
07-Feb-2023 Equillium to Present at the SVB Securities Annual Global Healthcare Conference Businesswire
07-Feb-2023 Amulet Capital Partners Acquires Eruptr Businesswire
07-Feb-2023 Interactome Bio Expands to Chicago's Portal Innovations to Further Foster Its Exosomes Research, Production, and Life Science Focused AI Software Development Newswire
07-Feb-2023 Marinus Pharmaceuticals to Present at Upcoming Investor Conferences Businesswire
07-Feb-2023 Enanta Pharmaceuticals to Present at the SVB Securities Global Biopharma Conference Businesswire
07-Feb-2023 Aldeyra Therapeutics Announces FDA Acceptance of New Drug Application for Reproxalap for the Treatment of Dry Eye Disease Businesswire
07-Feb-2023 Mattiq Launches With Revolutionary Approach to Developing Sustainable Materials Businesswire
07-Feb-2023 Deciphera Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results Businesswire
07-Feb-2023 Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease Businesswire
07-Feb-2023 Have model organisms evolved too far? University of Birmingham
07-Feb-2023 Catalent, Inc. Reports Second Quarter Fiscal 2023 Results Businesswire
07-Feb-2023 Freudenberg Medical Expands Medical Tubing Production to Massachusetts Businesswire
07-Feb-2023 KalVista Pharmaceuticals Presents Data at Western Society of Allergy, Asthma & Immunology (WSAAI) 60th Annual Scientific Session Businesswire
07-Feb-2023 Aplantex Announces the Composition of Its C-Suite Businesswire
07-Feb-2023 British biotech firm secures coveted FDA designation in bid to develop world’s first treatment for rare, incurable and deadly disease SynaptixBio
07-Feb-2023 iTeos to Present at SVB Securities Global Biopharma Conference iTeos Therapeutics
07-Feb-2023 AC Immune Awarded New Grants from MJFF and Target ALS Supporting Programs Targeting TDP-43 AC Immune
07-Feb-2023 Pharmaceutical Serialisation – What’s Coming Down the Line? Domino Printing Sciences